MassChallenge's Medical Device Portfolio

Neurava has developed wearable diagnostics for epilepsy patients including those at risk of SUDEP.

Starling develops predictive technology to identify chronic illnesses earlier.

ARMR Systems designs wearable first response hemorrhage control solutions to stop the bleeding anytime, anywhere.

PATH EX has developed a proprietary technology to selectively separate and capture bacteria and toxins from human blood.

Tympanogen is a medical technology company that develops ear, nose, and throat (ENT) devices and wound-healing therapies.

Aevice Health offers wearable devices for remote monitoring of respiratory conditions.

Biometry is a predictive analytics and clinical oversight to manage asthma.

Vigor Medical Technologies develops and will commercialise life saving innovative devices for treatment of chest trauma.

Lymphatica Medtech is a medical device development company developing a minimally invasive solution for chronic lymphedema.

RetiSpec is a medical imaging startup developing an eye scanner for early detection of Alzheimer's Disease pathology.

Regenosca develops biomaterials serving as an alternative to autologous tissue substitutes for soft tissue repair.

Imago Rehab offers a digital health solution for outpatient occupational therapy at home.

Adaptilens is a developer of an accommodating intraocular lens.

BIOS Health uses data-driven insights from the nervous system to build neural digital therapies - the next big trend in precision medicines.